These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19171843)

  • 1. Leptin and insulin resistance: good, bad, or still unclear?
    Oral EA; Burant C
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E394-5, author reply E396. PubMed ID: 19171843
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety.
    Simha V; Subramanyam L; Szczepaniak L; Quittner C; Adams-Huet B; Snell P; Garg A
    J Clin Endocrinol Metab; 2012 Mar; 97(3):785-92. PubMed ID: 22170723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical uses of leptin.
    Gorden P; Gavrilova O
    Curr Opin Pharmacol; 2003 Dec; 3(6):655-9. PubMed ID: 14644019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical utility of leptin therapy in metabolic dysfunction.
    Park JY; Gavrilova O; Gorden P
    Minerva Endocrinol; 2006 Jun; 31(2):125-31. PubMed ID: 16682936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical efficacy of the adipocyte-derived hormone leptin in metabolic dysfunction.
    Gorden P; Park JY
    Arch Physiol Biochem; 2006 Apr; 112(2):114-8. PubMed ID: 16931453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin treatment: facts and expectations.
    Paz-Filho G; Mastronardi CA; Licinio J
    Metabolism; 2015 Jan; 64(1):146-56. PubMed ID: 25156686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which comes first? The obesity or the insulin? The behavior or the biochemistry?
    Lustig RH
    J Pediatr; 2008 May; 152(5):601-2. PubMed ID: 18410757
    [No Abstract]   [Full Text] [Related]  

  • 8. Leptin Replacement Reestablishes Brain Insulin Action in the Hypothalamus in Congenital Leptin Deficiency.
    Frank-Podlech S; von Schnurbein J; Veit R; Heni M; Machann J; Heinze JM; Kullmann S; Manzoor J; Mahmood S; Häring HU; Preissl H; Wabitsch M; Fritsche A
    Diabetes Care; 2018 Apr; 41(4):907-910. PubMed ID: 29367426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Peptides; 2009 Jul; 30(7):1383-6. PubMed ID: 19394382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leptin deficiency and resistance.
    Garg MK; Saini JS
    J Assoc Physicians India; 2001 Nov; 49():1134. PubMed ID: 11868884
    [No Abstract]   [Full Text] [Related]  

  • 11. [The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin].
    Yu Y; Hu SK; Yan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Nov; 42(11):818-22. PubMed ID: 19176142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin: pathophysiology and implications for therapy.
    O'Rahilly S
    Eat Weight Disord; 2001 Sep; 6(3 Suppl):21. PubMed ID: 11706503
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome.
    Georgopoulos NA; Katsikis I; Florakis D; Panidis D; Kandarakis ED
    Fertil Steril; 2009 Jun; 91(6):e1. PubMed ID: 19362719
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of diet-induced weight gain on insulin sensitivity and plasma hormone and lipid concentrations in horses.
    Carter RA; McCutcheon LJ; George LA; Smith TL; Frank N; Geor RJ
    Am J Vet Res; 2009 Oct; 70(10):1250-8. PubMed ID: 19795940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of physiologic levels of triiodothyronine increases leptin expression in calorie-restricted obese rats, but does not influence weight loss.
    Luvizotto RA; Conde SJ; Síbio MT; Nascimento AF; Lima-Leopoldo AP; Leopoldo AS; Padovani CR; Cicogna AC; Nogueira CR
    Metabolism; 2010 Jan; 59(1):1-6. PubMed ID: 19846169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.
    Chang GR; Wu YY; Chiu YS; Chen WY; Liao JW; Hsu HM; Chao TH; Hung SW; Mao FC
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):188-98. PubMed ID: 19496779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced insulin resistance and obesity in children.
    Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
    Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.
    Paz-Filho G; Mastronardi C; Delibasi T; Wong ML; Licinio J
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):690-7. PubMed ID: 21340154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.